Skip to content
PT Prodia StemCell Indonesia Logo
  • Homepage
  • Tentang Kami
    • Visi & Misi
    • Tim Kami
    • Fasilitas
    • Karir
  • Layanan
  • Penelitian
    • Overview Penelitian
    • Fasilitas Penelitian
    • Layanan Penelitian
    • Publikasi
  • Uji Klinis
    • Cerebral palsy (CP)
  • Layanan Terapi
    • Daftar Layanan Terapi di ProSTEM
    • Laporan Hasil Terapi
    • Referensi Dokter & Rumah Sakit
    • Daftar Istilah
Home>Article>CASE REPORT: SAFETY PROFILE AND EFFICACY OF ALLOGENEIC UMBILICAL CORD-MESENCHYMAL STEM CELLS THERAPY VIA INTRACORONARY ROUTE FOR ACUTE MYOCARDIAL INFARCTION

CASE REPORT: SAFETY PROFILE AND EFFICACY OF ALLOGENEIC UMBILICAL CORD-MESENCHYMAL STEM CELLS THERAPY VIA INTRACORONARY ROUTE FOR ACUTE MYOCARDIAL INFARCTION

Respati Dyah2020-07-03T08:48:39+00:003 July 2020|Categories: Article|

Bagikan cerita ini

FacebookTwitterWhatsappEmail

Related Posts

  • Perkembangan Penelitian Sel Punca di Dunia dibandingkan di Indonesia
    Perkembangan Penelitian Sel Punca di Dunia dibandingkan di Indonesia
    Gallery

    Perkembangan Penelitian Sel Punca di Dunia dibandingkan di Indonesia

    21 September 2020 | 0 Comments
  • Retinitis Pigmentosa
    Retinitis Pigmentosa
    Gallery

    Retinitis Pigmentosa

    8 September 2020 | 0 Comments
  • Conditioned Medium VS Exosome
    Conditioned Medium VS Exosome
    Gallery

    Conditioned Medium VS Exosome

    1 September 2020 | 0 Comments
  • Popular
  • Recent
  • Spinal Cord Injury
    16 July 2019
  • Sel Punca Menjadi Harapan Pengobatan Masa Depan
    3 July 2014
  • 9 Hal yang Harus Diketahui Tentang Terapi Sel Punca (Part II)
    1 June 2015
  • ProSTEM hadir dalam Smart Living Prodia Edisi 58
    3 June 2016
  • Tiga Jenis Stem Cell Beserta Karakteristiknya
    24 September 2018
  • 6th Asian Cellular Theraphy Organization
    22 August 2015
  • 1st Surabaya International Conference in Stem Cell and Biomedical Sciences
    8 November 2018
  • AUDIT ISO 9001:2015
    16 August 2018
  • Potensi Mesenchymal Stem Cells (MSCs) untuk Terapi Total Body Rejuvenation
    22 June 2020
  • Terapi Stem Cell pada Penyakit Parkinson
    20 November 2014
  • Perkembangan Penelitian Sel Punca di Dunia dibandingkan di Indonesia
    21 September 2020
  • Retinitis Pigmentosa
    8 September 2020
  • ISEV 2020 : PROSTEM SEBAGAI MEMBER AKTIF DALAM INTERNATIONAL SOCIETY FOR EXTRACELLULAR VESICLE
    2 September 2020
  • Conditioned Medium VS Exosome
    1 September 2020
  • ISCT 2020: POTENSI EXTRACELLULAR VESICLES (EV) UNTUK TERAPI KLINIS
    10 August 2020
  • ISCT 2020: PENDEMI GLOBAL SARS-COV2, HARAPAN & TERAPI PENYEMBUHANNYA
    29 July 2020
  • ISCT 2020: MESENCHYMAL STROMAL CELLS: FULL CIRCLE FROM BASIC RESEARCH INSIGHTS TO CLINICAL TRIAL UPDATES
    28 July 2020
  • ProSTEM sebagai Member Aktif di Berbagai Organisasi Stem Cell Nasional & Internasional
    8 July 2020
  • CASE REPORT: EFFECT OF CONDTIONED MEDIUM NASAL DROP (CMND) AND INTRAVENOUS UMBILICAL CORD-MESENCHYMAL STEM CELL (UC-MSCSIV) ON THE FUNCTION OF CARDIO RESPIRATION AFTER 4 YEARS PERCUTANEOUS CORONARY INTERVENTION (PCI) IN RSPAD GATOT SOEBROTO
    3 July 2020
  • THE ROLE OF GROWTH MEDIUM IN THE POTENCY OF EPC-TYPE 2 DIABETES PATIENTS (A STUDY OF ALDHBRIGHT AS A MARKER OF THE POTENCY OF EPC)
    3 July 2020

PRODIA GROUP

Prodia
Prodia The Cro
Proline
Prodia OHI
Innodia
© Copyright ProSTEM | All Rights Reserved